Table 2. Expression level of miR-338-3p, anti-Dsg-1 and anti-Dsg-3 antibody during treatment.
| miR-338-3p | Anti-Dsg-1 antibody | Anti-Dsg-3 antibody | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Coefficient | SE | p-value | Coefficient | SE | p-value | Coefficient | SE | p-value | |
| After 6 weeks | −3.895 | 0.6548 | <0.001 | −20.833 | 8.7781 | 0.018 | −15.028 | 11.4126 | 0.188 |
| After 2 weeks | −2.704 | 0.5125 | <0.001 | −4.54 | 5.1338 | 0.377 | −16.91 | 9.6434 | 0.08 |
| Before treatment | 0a | 0a | 0a | ||||||
Notes:
SE, standard error.
Represented the control group.